Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
Finanznachrichten16d
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
today announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial for its lead asset, Decoy20. This approval will allow the Company to expand ...
Nasdaq16d
Indaptus Therapeutics Receives Clinical Trial Authorization from Health Canada to Expand Decoy20 Study
Indaptus Therapeutics, Inc. has received Clinical Trial Authorization from Health Canada ... Factors” included in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 ...
Yahoo Finance16d
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
today announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial for its lead asset, Decoy20. This approval will allow the Company to expand its ...
Yahoo Finance17d
Entrada gets UK MHRA authorisation to begin Phase I/II trial of DMD treatment
"Entrada gets UK MHRA authorisation to begin Phase I/II trial of DMD treatment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...
Mining Technology17d
WA starts new authorisation process trial for low-impact mining activities
Credit: Parilov/Shutterstock. Western Australia (WA) has launched a trial aimed at evaluating a new authorisation process for low-impact mining activities in the state’s mining sector. The eligible ...